Medtronic (NYSE: MDT) reported Q1 EPS of $0.62, $0.44 better than the analyst estimate of $0.18. Revenue for the quarter came in at $6.5 billion versus the consensus estimate of $5.44 billion.

Guidance:

Given the uncertainty on near-term financial results caused by the COVID-19 pandemic, the company is not providing formal annual or quarterly financial guidance at this time.

“We’re playing offense and finding a new gear at Medtronic,” said Martha. “We are driving toward faster and broader topline growth, not just as we emerge from the pandemic, but sustainable growth over the long-term.”

For earnings history and earnings-related data on Medtronic (MDT) click here.